Publikationen, an denen er mitarbeitet JOSÉ LUIS GARCÍA PUCHE (33)

2022

  1. Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective

    Molecular Genetics and Genomics, Vol. 297, Núm. 3, pp. 859-871

2020

  1. Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents

    Cells, Vol. 8, Núm. 11

  2. Evolución y desarrollo de la oncología en el siglo XX y la actualidad

    Evolución de la medicina en los últimos cincuenta años (1968-2018): Homenaje a la Universidad de Salamanca en su 800 aniversario (Los cuadernos del castor), pp. 381-402

  3. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy

    Breast Cancer Research, Vol. 21, Núm. 1

  4. Synthesis and Characterization of Specific Reverse Transcriptase Inhibitors for Mammalian LINE-1 Retrotransposons

    Cell Chemical Biology, Vol. 26, Núm. 8, pp. 1095-1109.e14

2018

  1. Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients

    Journal of Translational Medicine, Vol. 16, Núm. 1

2017

  1. A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: Biological and clinical implications of EGFR, AR and SNPs

    Oncotarget, Vol. 8, Núm. 41, pp. 70472-70482

  2. Association of circulating tumour cells with early relapse and 18F-fluorodeoxyglucose positron emission tomography uptake in resected non-small-cell lung cancers

    European Journal of Cardio-thoracic Surgery, Vol. 52, Núm. 1, pp. 55-62

  3. Circulating tumor cells: Markers and methodologies for enrichment and detection

    Methods in Molecular Biology (Humana Press Inc.), pp. 283-303

  4. Significance of EGFR expression in circulating tumor cells

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 285-296

2016

  1. Circulating tumor cells identify early recurrence in patients with non-small cell lung cancer undergoing radical resection

    PLoS ONE, Vol. 11, Núm. 2

  2. Dormant circulating tumor cells in prostate cancer: Therapeutic, clinical and biological implications

    Current Drug Targets, Vol. 17, Núm. 6, pp. 693-701

  3. Prognostic factor analysis of circulating tumor cells in peripheral blood of patients with peritoneal carcinomatosis of colon cancer origin treated with cytoreductive surgery plus an intraoperative hyperthermic intraperitoneal chemotherapy procedure (CRS + HIPEC)

    Surgery (United States), Vol. 159, Núm. 3, pp. 728-735

2015

  1. Biodynamic phenotypic and epigenetics changes of circulating tumor cells: Their application in cancer prognosis and treatment

    Epigenetics Territory and Cancer (Springer International Publishing), pp. 35-49

  2. Combined analysis of copy number alterations by single-nucleotide polymorphism array and MYC status in non-metastatic breast cancer patients: comparison according to the circulating tumor cell status

    Tumor Biology, Vol. 36, Núm. 2, pp. 711-718

  3. LINE-1 retrotransposons and their role in cancer

    Epigenetics Territory and Cancer (Springer International Publishing), pp. 51-99

  4. MiRNA in situ hybridization in circulating tumor cells - MishCTC

    Scientific Reports, Vol. 5

2014

  1. EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

    Oncotarget, Vol. 5, Núm. 17, pp. 7486-7497

2013

  1. CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy

    International Journal of Cancer, Vol. 133, Núm. 10, pp. 2398-2407